The size of the Asia Pacific Apheresis Market was worth USD 0.33 billion in 2021 and estimated to be growing at a CAGR of 12.58%, to reach USD 0.59 billion by 2026.
Apheresis is a medical procedure that involves removing whole blood from a donor or patient and separating the blood into individual components so that one particular component can be removed. The remaining blood components then are re-introduced back into the bloodstream of the patient or donor.
The presence of high unmet needs and rapidly increasing demand for platelets in the emerging Asia Pacific region is expected to serve this industry as future growth opportunities. As per the reports published by the National Centre for Biotechnology Information, chronic renal diseases have a prevalence of 8% to 16 worldwide.
The rise in the number of accidents leading to demand blood components, increasing incidences of chronic diseases and the development of new apheresis techniques are some of the factors enhancing the market growth.
Risk of blood getting infected, lack of skilled personnel to carry out the procedure and unavailability of both donor & specific blood group are some of the factors hindering the growth of the market.
This research report on the Asia-pacific Apheresis Market has been segmented and sub-segmented into the following categories:
By Product:
By Procedure:
By Application:
By Technology:
By End User:
By Country:
Geographically, The Asia Pacific is one of the most lucrative markets for the growth of the Apheresis market and is projected to grow the highest during the forecast period. Factors such as the growing prevalence of blood disorders requiring plasma and platelet transfusion, growing demographics and emerging economies in countries such as India and China are anticipated to lead the growth of the market in this region. The Asia Pacific region has a global share of 16% and has a CAGR of 12.58%.
Some of the notable companies playing a leading role in the Asia-pacific apheresis market profiled in the report are Asahi Kasei Medical Co., Ltd., Haemonetics Corporation, Terumo BCT, Inc., Fresenius Medical Care, Kawasumi Laboratories Inc., Cerus Corporation, HemaCare Corporation, Kaneka Corporation, B. Braun Melsungen AG, and Nikkiso Co., Ltd., Therakos, Inc., and Medica S.p.A.
1. Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 Epidemology
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 Product
5.1.1 Introduction
5.1.2 Apheresis devices
5.1.2.1 Plasma separators
5.1.2.2 Plasma component separators
5.1.2.3 Immunoadsorption Columns
5.1.2.4 Plasma Perfusion Columns
5.1.2.5 Hemoperfusion Columns
5.1.3 Apheresis disposables
5.1.4 Y-o-Y Growth Analysis, By Product
5.1.5 Market Attractiveness Analysis, By Product
5.1.6 Market Share Analysis, By Product
5.2 Procedure
5.2.1 Introduction
5.2.2 Donor Apheresis
5.2.3 Therapeutic Apheresis
5.2.4 Y-o-Y Growth Analysis, By Procedure
5.2.5 Market Attractiveness Analysis, By Procedure
5.2.6 Market Share Analysis, By Procedure
5.3 Application
5.3.1 Introduction
5.3.2 Renal Diseases
5.3.3 Neurology
5.3.4 Cancer
5.3.5 Hematology
5.3.6 Autoimmune Diseases
5.3.7 Cardiovascular Diseases
5.3.8 Y-o-Y Growth Analysis, By Application
5.3.9 Market Attractiveness Analysis, By Application
5.3.10 Market Share Analysis, By Application
5.4 Technology
5.4.1 Centrifugation
5.4.1.1 Intermittent Flow
5.4.1.2 Continuous Flow
5.4.2 Membrane Separation
5.4.3 Y-o-Y Growth Analysis, By Technology
5.4.4 Market Attractiveness Analysis, By Technology
5.4.5 Market Share Analysis, By Technology
5.5 End user
5.5.1 Introduction
5.5.2 Private Blood Collection Centres
5.5.3 Public Blood Collection Centres
5.5.4 Hospitals
5.4.5 Y-o-Y Growth Analysis, By End user
5.4.6 Market Attractiveness Analysis, By End user
5.4.7 Market Share Analysis, By End user
6. Geographical Analysis
6.1 Introduction
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.3.1 By Geographical Area
6.1.3.2 By Product
6.1.3.3 By Procedure
6.1.3.4 By Application
6.1.3.5 By Technology
6.1.3.6 By End user
6.1.4 Market Attractiveness Analysis
6.1.4.1 By Geographical Area
6.1.4.2 By Product
6.1.4.3 By Procedure
6.1.4.4 By Application
6.1.4.5 By Technology
6.1.4.6 By End user
6.1.5 Market Share Analysis
6.1.5.1 By Geographical Area
6.1.5.2 By Product
6.1.5.3 By Procedure
6.1.5.4 By Application
6.1.5.5 By Itechnology
6.1.5.6 By End user
6.2 China
6.3 India
6.4 Japan
6.5 South Korea
6.6 Australia
7. Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8. Market Leaders' Analysis
8.1 Asahi Kasei Medical Co., Ltd.
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 Haemonetics Corporation
8.3 Terumo BCT, Inc.
8.4 Fresenius Medical Care
8.5 Kawasumi Laboratories Inc.
8.6 Cerus Corporation
8.7 Hemacare Corporation
8.8 Kaneka Corporation
8.9 Braun Melsungen AG
8.10 Nikkiso Co., Ltd.
8.11 Therakos, Inc.,
8.12 Medica S.p.A.
9. Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10. Market Outlook and Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
Related Reports
Apr 2021
